Gene structure and organization of the human beta-secretase (BACE) promoter - PubMed (original) (raw)

Gene structure and organization of the human beta-secretase (BACE) promoter

Kumar Sambamurti et al. FASEB J. 2004 Jun.

Abstract

The first step in the generation of the amyloid-beta peptide (Abeta) deposited in the brains of patients with Alzheimer's disease (AD) is the processing of the larger Abeta precursor protein (APP) by an integral membrane aspartyl protease named the beta-site APP-cleaving enzyme (BACE). We present the genomic organization of the BACE gene. BACE mRNAs are synthesized as nine exons and eight introns from a 30.6 kb region of chromosome 11q23.2-11q23.3. Regulation of BACE may play an important role in regulating the levels of Abeta produced and is therefore likely to play an important role in AD. Herein, we report the cloning and detailed analysis of 3765 nucleotides of the promoter region of BACE and 364 nucleotides of the 5' untranslated region of the BACE mRNA (5' UTR). Characteristic "CAAT" and "TATA" boxes are absent within 1.5 kb of the transcription start site (TSS). The promoter region and 5' UTR contain multiple transcription factor binding sites, such as activator protein (AP)1, AP2, cAMP response element binding protein (CREB), estrogen responsive element (ERE), glucocorticoid responsive element (GRE), "GC" box, nuclear factor (NF)-kappaB, signal transducer and activator of transcription (STAT)1, stimulating protein (SP)1, metal-regulatory elements, and possible Zeste binding sites. Limited interspecies similarity was observed between the human sequence and corresponding genomic DNA from the rat and mouse sequences, but several transcription factor-binding sites are conserved. Thus, the BACE gene contains basal regulatory elements, inducible features and sites for regulated activity by various transcription factors. These results identify the important regions for functional analysis of the binding domains and neuron-specific expression (1). Such a study will allow us to further examine the possible role of changes in the promoter of BACE in AD pathogenesis.

PubMed Disclaimer

Cited by

Chronic mild sleep restriction accentuates contextual memory impairments, and accumulations of cortical Aβ and pTau in a mouse model of Alzheimer's disease.
Rothman SM, Herdener N, Frankola KA, Mughal MR, Mattson MP. Rothman SM, et al. Brain Res. 2013 Sep 5;1529:200-8. doi: 10.1016/j.brainres.2013.07.010. Epub 2013 Jul 13. Brain Res. 2013. PMID: 23856323 Free PMC article.
Icariside II inhibits lipopolysaccharide-induced inflammation and amyloid production in rat astrocytes by regulating IKK/IκB/NF-κB/BACE1 signaling pathway.
Zheng Y, Deng Y, Gao JM, Lv C, Lang LH, Shi JS, Yu CY, Gong QH. Zheng Y, et al. Acta Pharmacol Sin. 2020 Feb;41(2):154-162. doi: 10.1038/s41401-019-0300-2. Epub 2019 Sep 25. Acta Pharmacol Sin. 2020. PMID: 31554962 Free PMC article.
BACE1: More than just a β-secretase.
Taylor HA, Przemylska L, Clavane EM, Meakin PJ. Taylor HA, et al. Obes Rev. 2022 Jul;23(7):e13430. doi: 10.1111/obr.13430. Epub 2022 Feb 4. Obes Rev. 2022. PMID: 35119166 Free PMC article. Review.
BACE1 gene promoter is differentially regulated: detection of a novel promoter region for its cell type-specific regulation.
Lahiri DK, Maloney B, Ge YW. Lahiri DK, et al. J Mol Neurosci. 2006;28(2):193-210. doi: 10.1385/JMN:28:2:193. J Mol Neurosci. 2006. PMID: 16679558

Gene structure and organization of the human beta-secretase (BACE) promoter - PubMed (original) (raw)